The retroviral integrase (IN) protein catalyzes integration of the provirus and is essential for persistence of the infected state in vivo. Significant progress has been made in our understanding of this critical enzyme, especially its protein structure and the biochemical mechanism of the catalytic integration reaction (5, 14, 30) . Human immunodeficiency virus type 1 (HIV-1) IN is expressed and assembled into the virus particle as a part of a larger, 160-kDa Gag-Pol precursor polyprotein (Pr160 Gag-Pol ) that contains other Gag (matrix, capsid, nucleocapsid, and p6) and Pol (protease, reverse transcriptase [RT] , and IN) components. After assembly, Pr160
Gag-Pol is proteolytically processed by the viral protease to liberate the individual Gag and Pol components, including the 32-kDa IN protein (for a review, see reference 48) . Recent studies on IN function using replicating virus (in vivo) have suggested that in addition to catalyzing integration of the viral cDNA, IN may have other effects on virus replication (23, 35, 41) . In studies with proviral clones, it is obvious that IN gene mutations can affect virus replication at multiple levels. Mutations in the IN gene can affect the Gag-Pol precursor protein and alter assembly, maturation, and other subsequent viral events. IN gene mutations can also affect the mature IN protein and its organization within the virus particle and the nucleoprotein preintegration complex. Therefore, such mutations are pleiotropic and may alter virus replication through various mechanisms and at different stages in the virus life cycle. At least in part, this likely explains the diverse phenotypes that have been reported for IN mutant viruses. These have included viruses with defects in assembly, virion morphology, reverse transcription, nuclear import, and integration of the provirus (3, 7, 16, 44, 46) . While it is obvious that a full understanding of IN function requires analysis in higher-ordered systems that accurately reproduce both the viral and host cell environments, the pleiotropic nature of IN mutations has complicated such studies, and thus there remains a significant gap in our understanding of IN function in vivo.
Numerous in vitro studies have examined the biochemical and genetic properties of retroviral IN proteins and have provided most of the information for the currently accepted mechanism of the integration reaction. Using purified IN and oligonucleotides that represent the viral DNA ends, the in vitro integration reaction proceeds in two steps: IN removes two nucleotides from the 3Ј terminus of the viral DNA (terminal cleavage), which is then joined to a break in the cellular DNA (strand transfer) (6, 22, 43) . Through amino acid sequence alignment and in vitro activity studies of wild-type and mutant IN proteins, distinct functional domains that are conserved among retroviruses have been identified (12, 15, 33, 53) . In the case of HIV-1, the N-terminal domain (residues 1 to 50) contains a highly conserved HHCC motif. Mutation of this motif has variable effects on 3Ј processing and strand transfer, and its function remains poorly understood (15, 36, 51, 52) . The central region (residues 51 to 212) contains the invariant acidic residues D64, D116, and E152. Mutation of any of these residues causes a loss of all IN activity in vitro, suggesting that this region is the catalytic center of the enzyme (15, 36, 51) . The carboxyl-terminal region (residues 213 to 288) is least conserved and possesses nonspecific DNA binding properties. Certain mutations within the C-terminal region may not significantly affect the activity of IN in vitro, while causing a dramatic loss of virus infectivity (10, 16, 56) .
Reverse transcription is catalyzed by RT, and although reverse transcription can occur in vitro with recombinant RT, template, and primer, the process is more complex in vivo. In the context of a replicating virus, complete synthesis of the viral cDNA is not as simple as putting together different proteins and nucleic acids; rather, it is a complex, multistep process involving a number of transitional structures. Within the infected cell, reverse transcription takes place in the context of a nucleic acid-protein (nucleoprotein) complex that includes other viral and cellular factors (7, 18, 19, 29, 42) . Moreover, synthesis of the viral cDNA is greatly dependent on the proper execution of numerous molecular events that precede reverse transcription. In the case of HIV-1, several viral regulatory proteins are known to affect reverse transcription. Nef mutant viruses exhibit a 5-to 50-fold reduction in DNA synthesis (2, 45) . Pseudotyping with vesicular stomatitis virus glycoprotein (VSV-G) complements this defect, indicating that Nef affects uncoating and, in turn, reverse transcription (1). Vif mutant viruses produced by primary cells (nonpermissive) are defective in viral DNA synthesis (47, 54) . It remains unknown whether this is due to a direct or indirect effect of Vif on reverse transcription (9, 38) . Recently, Tat was shown to be required for efficient reverse transcription in infected cells (25) . The nucleocapsid protein, which facilitates strand transfer, may also increase the efficiency of reverse transcription (24, 37) . Mutations of the critical proline residues within the capsid domain of p55 Gag , which are important for binding cyclophilin A, result in virions that enter cells normally but fail to initiate viral DNA synthesis (4, 21, 40, 49) . Taken together, these results have shown that reverse transcription can be affected by multiple factors and at various levels of the virus life cycle. In the absence of a detailed understanding of the molecular mechanisms involved in the formation of infectious virus and the structure and composition of the reverse transcription complex, it is difficult to differentiate between factors that are specific and directly affect reverse transcription and those that involve other steps in virus replication, such as assembly, maturation, and uncoating.
Most in vivo studies of IN function have utilized virus derived from IN mutant proviral DNA, where detection of an integrated provirus was the primary marker for IN activity. Since mutations in the HIV-1 IN gene can cause defects in virus replication prior to integration, assays that rely on integration are not always useful for dissecting the function of IN at the virus replication level. By monitoring for products of reverse transcription in infected cells, certain HIV-1 IN mutants have been found to be defective in steps at or prior to the viral DNA synthesis stage. IN deletion mutant virus or those with mutations in the HHCC motif of IN have been shown to produce 10-to 20-fold less viral DNA following infection (16, 17, 35, 41) . Although these viruses are normal in proteolytic processing, virion protein composition, encapsidation of the genomic RNA, and virion-associated RT activity, it has remained unknown at what level(s) such IN mutations affect the virus life cycle (35, 41) . The production of infectious retroviral particles occurs through a highly coordinated sequence of events, and numerous examples have illustrated that even subtle changes in this process can have dramatic affects on events early in the virus life cycle, such as reverse transcription. The sensitivity of viral DNA synthesis to events that occur earlier is reflected by the high proportion of virions that are unable to initiate reverse transcription. Thus, it is apparent that an impairment in viral DNA synthesis may be a consequence of other defects and may not necessarily represent an intrinsic defect in reverse transcription itself.
To directly analyze the function of the mature IN protein itself, we used an approach developed in our laboratory that utilizes HIV accessory proteins (Vpr and Vpx) as vehicles to incorporate other proteins into HIV virions by their expression in trans as fusion proteins (39, (57) (58) (59) . By expression as fusion partners of Vpr, we recently demonstrated that fully functional RT and IN could be efficiently incorporated into HIV-1 particles independently of the Gag-Pol precursor protein (39, 57 
MATERIALS AND METHODS
Cells, HIV-1 clones, and expression plasmids. The 293T, HeLa-CD4, and HeLa CD4-LTR/␤-gal indicator cell lines (32) were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 U of penicillin and 0.1 mg of streptomycin per ml. The wild-type pSG3 wt , RT-INminus pSG3 S-RT , IN-minus pSG3 S-IN , and IN mutant pSG3 D116A proviral clones have been described previously (38, 57) . The RNase H mutant pSG3 D443N proviral clone was constructed by replacing the aspartic acid residue with an asparagine residue at position 443 of RT, using PCR methods. This mutation inactivated the RNase H activity of RT. The pHy-SG3 IN AA35A clone was constructed by inserting alanine residues into the hygromycin-resistant pHy-SG3 clone at each of the three amino acid positions that comprise the catalytic center of the IN protein (D64A, D116A, and E152A). The Vpr-IN, Vpr-RT, and Vpr-RT-IN expression vectors were described earlier (38, 57 Transfections and virus purification. DNA transfections were performed with monolayer cultures of 293T cells by the calcium phosphate DNA precipitation method according to the recommendations of the manufacturer (Stratagene). Unless otherwise noted, all transfections were performed with 4 g of each plasmid. Supernatants from the transfected cultures were collected after 48 h, clarified by low-speed centrifugation (1,000 ϫ g, 10 min), and analyzed for RT activity as described previously (13) and for HIV-1 capsid protein concentration by p24 antigen enzyme-linked immunosorbent assay (ELISA) (Coulter Inc.). Virions were pelleted by ultracentrifugation through cushions of 20% sucrose with a Beckman SW41 rotor (125,000 ϫ g, 2 h).
Semiquantitative detection of viral DNA. The PCR technique used to monitor the synthesis of viral DNA in infected cells was similar to those described earlier (4, 41, 54) . Briefly, 500-ng equivalents (p24 antigen) of transfection-derived virus were used to infect one million HeLa-CD4 cells. To control for variation in virus entry by the different mutant viruses, the intracellular p24 antigen concentration of each virus was determined 4 h after infection as described earlier (39) . At 4 and 18 h after infection, cells were lysed and total DNA was extracted by organic methods. The DNA extracts were resuspended in 200 l of distilled water and treated with the DpnI restriction endonuclease to digest bacterially derived plasmid DNA (from transfection). The viral cDNA synthesized de novo following infection is resistant to cleavage by DpnI. To eliminate any effect of differential virus entry on the detection of viral DNA products in infected cells, the DNA extracts were normalized to 250 pg of p24 antigen for PCR amplification. The wild-type DNA extract was adjusted to 250 pg (100%), 100 pg (40%), 40 pg (16%), 16 pg (6.4%), and 6.4 pg (2.5%). The DNA extracts were then subjected to 30 rounds of PCR amplification with primers designed to detect early (R-U5 [sense nucleotides 1 to 22, 5Ј-GGTCTCTCTGGTTAGACCAGA-3Ј; antisense nucleotides 181 to 157, 5Ј-CTGCTAGAGATTTTCCACACTGAC-3Ј]), intermediate (U3-U5 [sense nucleotides 8687 to 8709, 5Ј-ACACACAAGGCTACT TCCGTGA-3Ј; antisense nucleotides 181 to 157, 5Ј-CTGCTAGAGATTTTCC ACACTGAC-3Ј]), and late (R-gag [sense nucleotides 1 to 22, 5Ј-GGTCTCTC TGGTTAGACCAGA-3Ј; antisense nucleotides 355 to 334, 5Ј-ATACTGACGC TCTCGCACCCAT-3Ј]) products of reverse transcription. The PCR products were separated on a 1.5% agarose gel and visualized by ethidium bromide staining.
Analysis of RT-IN interaction. Expression of the recombinant glutathione S-transferase (GST) and GST-IN proteins was induced with 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside), and the bacterial pellet was lysed in buffer Y-0.2 M NaCl (50 mM HEPES [pH 7.0], 1 mM EDTA, 0.5% IGEPAL CA-630, 200 mM NaCl, 2 g of aprotinin per ml, 2 g of leupeptin per ml, 2 g of pepstatin A per ml, 18 g of phenylmethylsulfonyl fluoride per ml) via six freeze-thaw cycles, followed by lysozyme (0.2 g/liter) treatment for 30 min. The lysates, recovered via centrifugation at 101,000 ϫ g for 30 min, were bound to a 0.5-ml suspension of freshly prepared glutathione beads (G-beads). The beads bound to GST and GST-IN were washed three times with 50 ml of buffer Y-0.2 M NaCl, followed by quantitation of the protein along with standards by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The expression of recombinant HIV-1 RT heterodimers was induced and lysis was performed as described previously (31), except that the lysis buffer contained 300 mM NaCl and HEPES (pH 7.2). After extraction, the samples were centrifuged at 101,000 ϫ g for 30 min, and the lysates were recovered as supernatants. Fifty microliters of beads bound with equimolar quantities of GST or GST-IN proteins was incubated with 100 l of crude bacterial lysates containing RT heterodimer in HND buffer (20 mM HEPES [pH 7.0], 120 mM NaCl, 4 mM MgCl 2 , 5 mM dithiothreitol, 0.1% IGEPAL, 100 mg of bovine serum albumin per ml, 2 g of aprotinin per ml, 2 g of leupeptin per ml, 2 g of pepstatin A per ml, 18 g of phenylmethylsulfonyl fluoride per ml). The reaction was allowed to proceed with slow mixing for 1 h at 4°C. The beads were washed five times with 1 ml of buffer Y-50 mM NaCl. The washed pellets were resuspended in SDS-PAGE loading buffer, boiled for 10 min, cleared by centrifugation, and applied to SDS-polyacrylamide gels.
RESULTS

Certain IN mutant viruses are impaired in reverse transcription.
To study the function of the mature IN protein, we first generated and characterized different IN mutant viruses for their ability to synthesize viral DNA. These included S-IN (IN minus), H12A and H16A (the mutations disturb the conserved HHCC motif located in the N terminus), F185A (the mutation is structurally positioned near the catalytic center), ⌬22 (the mutation deletes 22 amino acids from the C terminus), and D116A (the mutation destroys enzymatic activity). HeLa-CD4 cells were infected with 500 ng of each virus and analyzed 18 h later for the presence of early (R-U5), intermediate (U3-U5), and late (R-gag) DNA products of reverse transcription. Ten-to 20-fold less early (R-U5) DNA was detected in cells infected with all of the IN mutant viruses, with the exception of D116A (Fig. 1, lanes 2 to 7) . Similar changes were detected for the intermediate and late DNA products. No viral DNA was detected in cells that were infected with the control S-RT virus (lacking both RT and IN [57] ). The RNase H-defective RT mutant virus (D443N) produced the early R-U5 DNA product in amounts similar to those produced by wild-type virus, but the levels of the intermediate and late DNA products were dramatically reduced, indicating that the strong-stop DNA product is relatively stable for at least 18 h in infected cells. At 4 h after infection, the relative proportions of wild-type and IN mutant DNA products were similar to those measured at 18 h (data not shown). The reverse transcription products (detected by PCR) were confirmed to have been synthesized within the infected cells, since zidovudine completely inhibited the detection of mutant and wild-type viral DNAs (data not shown). Similar concentrations of intracellular CA protein were detected for both the wild-type and mutant viruses, indicating that the impaired DNA synthesis of the IN mutants was not due to a block at the level of virus entry (Table 1) . Also, all of the other mutant viruses (except the S-IN mutant) exhibited normal levels of virion-associated RT activity ( Table 1 ). The analysis for two-long-terminal-repeat circular viral DNA (data not shown) confirmed that the nuclear import of nascent viral cDNA of each IN mutant was not impaired in HeLa cells (dividing cells).
Since circular forms of viral DNA in the nuclei of infected cells can express Tat protein, we exploited the HeLa-CD4-LTR/␤-gal cell line (32) as a biological indicator for a defect in viral DNA synthesis. Table 1 shows that the infectivity of the IN mutant viruses was decreased 20-to 100-fold compared to that of the integration-defective D116A virus (which supports wild-type levels of viral DNA synthesis). These results indicated that the loss of infectivity could not be explained solely by a defect in integration, but rather, they suggested a defect at the level of viral DNA synthesis. These results are consistent with our analysis for viral DNA. Taken (Fig. 2B ). These results demonstrate that the Vpr-IN fusion protein, which was assembled into virions together with mutant Gag-Pol precursor protein (S-IN, H12A, H16A, F185A, or ⌬22, respectively), restored viral DNA synthesis. Using the MAGI assay, we confirmed that Vpr-IN also restored virus infectivity, to between 15 and 58% of that of wild-type virus (Table 1) . It is important to note that while the trans-IN protein complemented viral DNA synthesis and infectivity, it did not correct the defect in Gag processing (excess p39) or virion-associated RT activity ( Fig. 2A and Table 1 ).
trans-IN protein acts after virus assembly to promote viral DNA synthesis.
To further analyze the effect of the IN protein on reverse transcription, the RT-IN-minus provirus (S-RT) (57) was complemented with the Vpr-RT fusion protein (Fig.  3A) . While high RT activity levels were associated with the progeny virions, they remained severely defective in DNA synthesis. However, when S-RT virus was complemented with both Vpr-RT and Vpr-IN together or with Vpr-RT-IN, viral DNA synthesis was increased 40-to 80-fold compared with that of Vpr-RT-complemented virions (Fig. 3B) . By performing complementation experiments with the same virus background (S-RT), we were able to directly examine the effect of the IN protein on reverse transcription. Taken together, these results strongly suggest that the failure of the IN mutant viruses to efficiently support reverse transcription was not due to a defect at the level of Pr160
Gag-Pol but, rather, that the mature IN protein is important for viral DNA synthesis in vivo.
Additional evidence arguing against the notion that the trans IN protein complements a defect during assembly comes from our analysis of the cleavage-deficient Vpr-⌬PC IN fusion protein. In parallel with the experiment described above, S-RT virions were complemented with both Vpr-RT and Vpr- (Fig. 3B, compare lanes 3 and 4) . IN, H12A, H16A, F185A , ⌬22, D116A, S-RT, and D443N) proviral clones were introduced into 293T cells by calcium phosphate DNA transfection methods. Forty-eight hours later, culture supernatants were filtered through 0.45-m-pore-size filters and analyzed by HIV-1 p24 antigen ELISA (Coulter Inc.). The virus-containing culture supernatants were normalized to 500 ng of p24 antigen (CA), treated with RNase-free DNase H (20 U/ml for 2 h) (Promega Corp.), and placed on cultures of HeLa-CD4 cells at 37°C. After 4 h, the cell monolayers were washed, trypsinized, resuspended in fetal bovine serum, and divided into two aliquots. One aliquot set (which contained 1/10 of the total number of cells) was lysed in phosphate-buffered saline containing 1% Triton X-100 and analyzed by p24 antigen ELISA to quantify intracellular CA protein ( Table 1 ). The other aliquot set was placed back in culture medium at 37°C for an additional 14 h. The cells were then washed, and total DNA was extracted by organic methods. For each DNA extract, 250-pg equivalents (p24 antigen) were analyzed by PCR methods for early (R-U5), intermediate (U3-U5), and late (R-gag) viral DNA products of reverse transcription. The amplified products were resolved on 1.5% agarose gels and stained with ethidium bromide. To assess the relative amount of each of the amplified DNA products, four serial 2.5-fold dilutions of the wild-type (SG3 wt ) DNA were analyzed in parallel. The undiluted 250-pg sample was arbitrarily set to 100. As standards, 10 to 6,250 copies of the pSG3 wt clone were also analyzed by PCR under identical conditions. As a control for the efficiency of DpnI cleavage of potential carryover plasmid DNA, 6,250 copies of pSG3 wt DNA were analyzed after digestion with DpnI as described previously (26) . The virus origin of the ethidium bromide-stained DNA products was confirmed by Southern blot analysis with a homologous nick-translated probe (data not shown). The ethidium bromide staining intensity of each amplified DNA produce was measured with a Lynx 5000 molecular biology workstation (Applied Imaging, Santa Clara, Calif.). The data shown are from a representative experiment that was repeated three times, each time with independent transfection-derived virus preparations. 2 (data not shown), only a modest (2-to 3-fold) increase in HIV-1 DNA synthesis was observed, compared with a 10-to 20-fold increase induced by the homologous IN (Fig. 5A) . However, when integration-defective mutant virus was complemented with Vpr-IN 2 , the integration frequency was increased nearly 100-fold (Fig. 5B ). This result indicated that the HIV-2 IN protein was able to associate with the HIV-1 reverse transcription complex but that this alone was not sufficient to support DNA synthesis. This strongly suggests that specific interactions between the homologous IN and other viral components of the reverse transcription complex are required to promote viral cDNA synthesis in vivo.
Direct physical interaction between the HIV-1 RT and IN proteins. One explanation for the effect of IN on reverse transcription is that IN affects RT via a direct physical interaction. Several observations suggest that HIV RT and IN may form a heterodimeric complex: (i) the two proteins are known to coexist as a complex in some retroviruses (30, 50) , (ii) the car- a Four micrograms of DNA of each of the viral clones was transfected into 293T cells, either alone (Ϫ) or together with 2 g of the pLR2P-vprIN expression plasmid (ϩ), by calcium phosphate DNA precipitation methods. Forty-eight hours later, the culture supernatants were harvested, clarified by low-speed centrifugation, filtered through 0.45 m-pore-size filters, and saved as stocks.
b RT activity (counts per minute; 10 3 /25 l) of culture supernatant virus stocks. c HIV-1 p24 antigen (CA protein) concentration (nanograms per milliliter) in culture supernatants. The supernatant stocks were analyzed by HIV-1 antigen ELISA as described by the manufacturer (Coulter Inc.).
d Virus entry was quantified by measuring the intracellular HIV-1 CA protein concentration 4 h after infection of the HeLa-CD4 cells with 500-ng equivalents (p24 antigen) of each virus stock. The results represent nanograms of p24 antigen per 10 6 cells. e Virus infectivity was measured by the MAGI assay as described earlier (32) . The infectivity of mutant virus relative to that of wild-type virus is indicated in parentheses. The infectivity of wild-type SG3 virus was arbitrarily set to 100.
f Values represent means from at least two independent assays.
FIG. 2. Analysis of Vpr-IN-complemented virions.
Four micrograms of the wild-type and mutant proviral DNA clones was individually transfected (Ϫ) into 293T cells and cotransfected (ϩ) with the pLR2P-vprIN expression plasmid. Forty-eight hours later, the culture supernatants were collected, passed through 0.45-m-pore-size filters, and analyzed for HIV-1 p24 antigen concentration by ELISA. (A) Immunoblot analysis. One-half of the filtered supernatant was centrifuged (125,000 ϫ g for 2 h) over cushions of 20% sucrose. The pellets were lysed and examined by immunoblot analysis with anti-IN (␣-IN) (top), anti-Vpr (middle), and anti-Gag (bottom) antibodies as described earlier (57) . Vpr-IN-containing H16A virions were identical to the H12A virions (data not shown). (B) The trans-IN protein rescues viral DNA synthesis. Five hundred nanograms of wild-type virus and each of the mutant viruses was used to infect cultures of HeLa-CD4 cells. After 4 h, the cell monolayers were washed, trypsinized, resuspended in fetal bovine serum, and divided into two aliquots. One aliquot set was analyzed by p24 antigen ELISA as described for Fig. 1 . The other aliquot set was placed back in culture medium at 37°C. At 18 h postinfection, the cells were washed and total DNA was extracted by organic methods. The extracts were normalized for intracellular CA protein concentration and analyzed by PCR for viral DNA products of reverse transcription as described for Fig. 1 . The data are from a representative experiment that was repeated three times, each time with independent virus preparations.
boxy-terminal domain of RT (RNase H) and the central core domain of IN are structurally similar (11, 14) , and (iii) in murine leukemia virus, IN and RT proteins can be coimmunoprecipitated with antibodies to either protein (27) . Therefore, we examined whether a GST-HIV IN fusion protein would interact with an HIV-1 RT heterodimer by using an in vitro binding assay. Figure 6B shows that the GST-IN protein efficiently pulls down recombinant RT heterodimer protein from crude bacterial lysates. The specificity of RT-IN interaction was indicated by the inability of empty G-beads or GST proteinbound G-beads to pull down RT. The possibility that nucleic acids facilitated the association of RT and IN proteins was ruled out by first pretreating the RT-IN reaction mixture with micrococcal nuclease, which did not decrease the amount of RT pulled down (Fig. 6C) . The demonstration of a physical interaction between RT and IN suggests that the two proteins exist as a complex within the nucleoprotein reverse transcription complex. While HIV-1 nuclear preintegration complexes have been shown to contain RT (8, 42) , no specific role for IN in reverse transcription has been previously demonstrated.
DISCUSSION
From assembly to integration of the provirus, the infectious HIV structure progresses through a succession of precisely coordinated events involving many intra-and intermolecular interactions and rearrangements. A detailed understanding at the virus replication level of the molecular mechanisms that are involved in assembly, maturation, uncoating, and the early stages of reverse transcription remains obscure. In part, this is due to the nature of the process by which the virion proteins are assembled. In the later stages of the virus life cycle, the structural proteins of the virion are synthesized and assembled as precursor polyproteins. Each precursor plays a specific role in the assembly process. After assembly, the structures of the Gag and Gag-Pol precursor polyproteins change due to proteolytic processing. Processing of the Gag and Gag-Pol precursors drives the metamorphosis of the immature (noninfectious) virion into one with a condensed, mature core structure containing the diploid single-stranded viral RNA genome, nucleocapsid, RT, integrase, and primer tRNA (for a review, see reference 48). In the early stage of the virus life cycle, after entry into the host cell, the virus core structure undergoes additional rearrangements (uncoating) to form a nucleoprotein complex structure that supports reverse transcription. After reverse transcription is completed, IN catalyzes integration of the nascent viral cDNA into the host cell chromosomes. It is obvious that mutations in IN (and other domains within Gag and Pol) can affect both late-and early-stage events. As a result, it is inherently difficult to specifically define the effect of such mutations on the virus life cycle. In this study we used trans-complementation methods to distinguish between the effects of mutations in the mature IN protein and its function during the early events of the virus life cycle versus the effects of mutations in the Gag-Pol precursor protein and late stage events. For the first time, our results show that the mature IN protein itself is required for efficient reverse transcription, independent of its enzymatic function. Moreover, our data indicate that the IN protein promotes the initiation step of reverse transcription through virus type-specific interactions with other components that comprise the reverse transcription initiation complex.
Our analysis indicated that a change in the structure and function of the Gag-Pol precursor protein was not responsible for the impairment of viral DNA synthesis. Strong evidence for this comes from experiments showing that trans-IN protein restores infectivity (Table 1 ) and viral DNA synthesis (Fig. 2  and 3 ) to viruses that contain a mutated Gag-Pol precursor wt was also transfected as a control. Forty-eight hours later, supernatant virions were prepared and used to infect HeLa-CD4 cells exactly as described in the legend to Fig. 1 . The infected cells were washed 18 h later, and total DNA was extracted and treated with DpnI endonuclease. Early (R-U5) and late (R-gag) viral DNA products of reverse transcription were amplified by PCR and analyzed as described above. The data are from a representative experiment that was repeated three times, each time with independent virus preparations. (B) Complementation of proviral DNA integration. To directly compare the ability of the heterologous trans-IN 2 protein to support integration of the provirus with that of the homologous IN protein, the hygromycin-resistant, integration-defective Hy-SG3 IN AA35A clone was used for analysis. Hy-SG3 IN AA35A contains a mutation in each of the three residues that comprise the catalytic center of the IN protein (D64A, D116A, and E152A) and efficiently synthesizes viral DNA after entry. Four micrograms of Hy-SG3 AA35A was cotransfected with 2 g of the Vpr-IN, and Vpr-IN 2 expression plasmids, respectively. The virions were pseudotyped by including the pCMV-VSV-G env vector in the transfection reactions. Forty-eight hours after transfection, the culture supernatants were filtered through 0.45-mpore-size filters and analyzed for HIV-1 p24 antigen concentration by ELISA. Twenty-five nanograms (p24 antigen) of each of the pseudotyped virus stocks was used to infect cultures of HeLa cells. The infected cells were maintained in hygromycin selection medium for 12 days and then stained to identify resistant colonies as described earlier (35) . These results were highly reproducible in three independent experiments. The data shown are from a single representative experiment.
age site of Vpr-IN). Therefore, their expression, transport to the surface of the infected cell, and assembly into virions would likely be the same. However, the Vpr-⌬PC IN fusion protein is unable to restore infectivity and viral DNA synthesis above the levels of those for IN-minus virus, indicating that the IN protein supports viral DNA synthesis after virus assembly and proteolytic processing. It is noteworthy that some mature IN protein is detected in virions complemented with the Vpr-⌬PC IN fusion protein (Fig. 3A ), yet the virions remain noninfectious. It is likely that the mutation at the PЈ residue reduces not only the total extent of cleavage but also the rate at which IN is liberated, which in turn could alter the proper association of IN with the reverse transcription complex during condensation of the virus core. Additional evidence that changes in the structure of the Gag-Pol precursor protein were not responsible for the defect in viral DNA synthesis comes in part from our earlier results, which demonstrated that the Vpr-RT-IN fusion protein, but not the Vpr-RT fusion protein, could efficiently complement (Ͼ80% of wild-type levels) the defect in infectivity of RT-IN-minus virus (S-RT) (57) . We have now extended those findings by analyzing whether the S-RT mutant virions synthesized viral DNA when complemented with only the Vpr-RT fusion protein. Our data clearly show that in the absence of IN, RT is not sufficient to overcome the defect, even though proteolytic processing of the Gag precursor protein, maturation of the virus particle, and RT/p24 ratios were similar to those for RT-IN-minus virions that were complemented with (Fig. 4) . Similarly, the heterologous HIV-2 trans-IN protein also efficiently supported integration of HIV-1 DNA but did not support reverse transcription, indicating that the HIV-2 IN protein does associate with the nucleoprotein preintegration complex (Fig. 5) . The results of our trans-complementation experiments and our data showing a direct physical interaction between IN and RT clearly show that the mere association of the IN protein with the nucleoprotein complex is not sufficient for DNA synthesis but rather that the IN protein promotes reverse transcription through virus-specific (not cellular) interactions with other viral components in the reverse transcription complex.
Recent studies have suggested that reverse transcription may be regulated at three defined stages: initiation, transition (the point between initiation and elongation), and elongation (34) . The efficiency of initiation requires specific and multiple interactions between viral and cellular components, including the viral RNA genome, RT, nucleocapsid, and primer tRNA. Also included are interactions of the primer tRNA with the primer binding site and an A-rich loop located 12 to 17 nucleotides upstream of the primer binding site (28, 55) . Disturbances of any of these interactions may cause defects in the initiation of reverse transcription in vivo. Initiation is a The RT-IN interaction is resistant to micrococcal nuclease digestion. The experiment was similar to that described above except that the HND buffer contained 50 mM Tris-HCl (pH 8.0) and 1 mM CaCl 2 , and prior to addition of the bacterial lysates, the samples were preincubated with 100 U of micrococcal nuclease at 37°C for 10 min, and the nuclease was inactivated with EGTA. slow process and proceeds at a highly reduced processivity compared with elongation (34) . This functional distinction suggests that the structures and compositions of the initiation and elongation complexes are different. Our analysis of viral DNA elongation shows that for the H12A, H16A, F185A, and ⌬22 IN mutant viruses, the minus-strand strong-stop DNA product was produced in amounts similar to those of the intermediate and late DNA products. Also, it was shown that the trans-IN protein supported the synthesis of minus-strand strong-stop DNA to an extent similar to that for later DNA products. These results indicate that the IN protein is required either prior to or at the initiation stage of reverse transcription. Our data clearly exclude a defect at the level of virus entry (Table  1) . Moreover, it seems unlikely that IN protein supports uncoating after virus entry. Recent studies with nef and certain gag mutant viruses have shown that defects in uncoating, which impair virus DNA synthesis, can be overcome if the normal virus entry pathway is bypassed via pseudotyping with the VSV-G envelope (1) . Our data show that VSV-G pseudotyping of IN mutant viruses did not overcome the defect in infectivity. Our findings that show a direct physical interaction between the IN and RT proteins strongly suggest that the IN protein is directly involved in reverse transcription in vivo. In the case of the avian retroviruses, the IN protein comprises an integral component of the RT heterodimer; an RT-IN polypeptide makes up the beta subunit (30, 50) . Taken together, these results suggest that the IN protein forms an integral part of the reverse transcription initiation complex and specifically promotes interactions between RT, the genomic RNA, and primer tRNA 3 Lys that facilitate initiation.
The apparent fragility of the reverse transcription initiation complex (34) and the sensitivity of reverse transcription to mutations in any of the three IN subdomains may suggest that the DNA synthesis function of IN could be particularly vulnerable to anti-IN compounds. Of particular interest is the fact that disturbances in the highly conserved HHCC motif caused defects in virus replication at two levels, in both reverse transcription and integration (Fig. 4) . Therefore, it is possible that drugs which target this motif could inhibit virus replication at both levels. Finally, our findings validate a novel and powerful approach to dissect important molecular processes of HIV-1 at the virus replication level.
